Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 10, Pages 1277-1284Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.2011.38.5401
Keywords
-
Categories
Funding
- French National Cancer Institute
- La Caisse Nationale de L'Assurance Maladie des Travailleurs Salaries
- Central Agricultural Workers and Farmers' Mutual Benefit Fund
- Regime Social des Independants
- cancer patients' association (La Ligue Nationale contre le Cancer
Ask authors/readers for more resources
Purpose To investigate the effects of clinical, sociodemographic, and occupational factors on time to return to work (RTW) during the 2 years after cancer diagnosis and to analyze whether sex differences exist. Patients and Methods This study was based on a French national cross-sectional survey involving 4,270 cancer survivors. Time to RTW was estimated through the duration of sick leave of 801 cancer survivors younger than 58 years who were employed during the 2-year survey. Multivariate analysis of the RTW after sick leave was performed using a Weibull accelerated failure time model. Results We found some sex differences in the RTW process. Older men returned to work more slowly than older women (P =.013), whereas married men returned to work much faster than married women (P =.019). Duration dependence was also sex-specific. In men, the time spent on sick leave was independent of the probability of returning to work, whereas in women, this duration dependence was positive (P <.001). For both men and women, clinical factors including chemotherapy, adverse effects, and cancer severity were found to delay RTW (P =.035, P =.001, and P =.001, respectively). Survivors investing most strongly in their personal lives also delayed their RTW (P =.006), as did those with a permanent work contract (P =.042). The factor found to accelerate RTW was a higher educational level (P =.014). Conclusion The RTW process 2 years after cancer diagnosis differed between men and women. A better knowledge of this process should help the national implementation of more cost-effective strategies for managing the RTW of cancer survivors. J Clin Oncol 31: 1277-1284. (C) 2013 by American Society of Clinical Oncology
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available